PPD, Inc. (Nasdaq: PPDI), a pharmaceutical discovery and development company, announced plans to participate in the UBS Warburg Life Sciences Conference Oct. 7-10 at the Plaza Hotel in New York City.
Company officials say PPD Chief Executive Officer Fred Eshelman will speak at the conference where he will discuss PPD’s business strategy and existing market opportunities, according to a statement released by the firm.
A live audio broadcast of Eshelman’s presentation will be available on PPD’s Web site.
PPD: www.ppdi.com
